Last reviewed · How we verify

NCT06735092

Exercise Therapy and Orthoses in Lateral Elbow Tendinopathy: Comparative Effects

Recruiting now NA Last updated 16 December 2024
What this trial tests

NA trial testing Exercise-Only Group (Control Group) in Lateral Epicondylitis in 45 participants. Currently enrolling.

Timeline
2 December 2024
Primary endpoint
15 August 2025
15 October 2025

Quick facts

Lead sponsorIstanbul University - Cerrahpasa
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment45
Start date2 December 2024
Primary completion15 August 2025
Estimated completion15 October 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul University - Cerrahpasa

Who can join

Adults 18 to 65, any sex, with Lateral Epicondylitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to address the inconsistencies in the literature by investigating the effects of a forearm counterforce brace and a wrist splint, used in addition to exercise therapy, on pain, functionality, and grip strength in individuals diagnosed with lateral elbow tendinopathy, compared to those receiving exercise therapy alone.The findings aim to provide valuable insights into clinical practice by highlighting the roles of both orthosis use and exercise in the treatment of lateral elbow tendinopathy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Lateral Epicondylitis

Currently open trials in the same condition.

Other Istanbul University - Cerrahpasa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06735092.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing